Skip to main content

Client News

CENTOGENE Launches PICOPglobal: Two Year Global Study on Colon- and Pancreas-Carcinoma

27th June 2019

Results of NOXXON annual general shareholders meeting

27th June 2019

Newron Pharmaceuticals now also listed on the primary market of the Düsseldorf Stock Exchange and on XETRA

27th June 2019

Vivoryon Therapeutics AG enters myeloid immune checkpoint drug discovery, and collaborates with the University of Kiel to select cancer therapy candidates from its QPCTL inhibitor portfolio

27th June 2019

NOXXON announces launch of capital increase right issue for an amount of up to Euro 3.9 M

26th June 2019

MagForce AG successfully resolves and completes capital increase from authorized capital under exclusion of statutory subscription rights

25th June 2019

CENTOGENE Four Year Study Reveals Importance of Lyso-Gb1 in Monitoring Gaucher Disease Patients

25th June 2019

Verona Pharma Strengthens its Clinical Team Ahead of Phase 3 Development of Ensifentrine

25th June 2019

Expedeon AG introduces Lightning-Link® Metal Labelling Kits to support single cell analysis

24th June 2019

NOXXON announces leading international pharma to evaluate NOX-A12 in new indication

24th June 2019